UPSHER-SMITH 150 mg Pill - gray & yellow capsule/oblong, 11mm
Pill with imprint UPSHER-SMITH 150 mg is Gray & Yellow, Capsule/Oblong and has been identified as Topiramate Extended-Release 150 mg. It is supplied by Upsher-Smith Laboratories, Inc.
Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Epilepsy; Seizures; Seizure Prevention and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for UPSHER-SMITH 150 mg
- UPSHER-SMITH 150 mg
- 150 mg
- Gray & Yellow
- 11.00 mm
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Upsher-Smith Laboratories, Inc.
- Inactive Ingredients
hypromellose 2910 (6 mPa.s),
ethylcellulose (10 mPa.s),
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|00832-1075||Upsher-Smith Laboratories Inc.|
|00245-1075||Upsher-Smith Laboratories Inc.|
Related images for "UPSHER-SMITH 150 mg"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,314)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Topiramate drug information
- Topiramate (Advanced Reading)
- Topiramate Tablets
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
- Topiramate Extended-Release Capsules
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.